CDKN2A and glioblastoma: Case 1 showed piloid morphology with ATRX mutation, loss of p16 (CDK2NA deletion), and a longer survival time compared with Case 2, which showed morphology and a molecular status similar to sporadic IDH-wildtype glioblastomas (nuclear ATRX and p16 retained).